[shareaholic app=”share_buttons” id=”25900514″]
In November of 2016, voters in the state of California passed Prop 64, legalizing marijuna for adult use. Now, state lawmakers have formally called on the federal government to reclassify marijuana (currently a Schedule 1 Narcotic).
“The Legislature urges the Congress of the United States to pass a law to reschedule marijuana or cannabis and its derivatives from a Schedule I drug to an alternative schedule, therefore allowing the legal research and development of marijuana or cannabis for medical use”. The bill, SJR-5, was approved by the California Assembly last Thursday with a vote of 60/10.
The Controlled Substance Act’s Schedule I, the most restrictive catergory, is reserved for drugs with no “Medical Value“, and “High Potential for Abuse“. For years researchers have complained that the Schedule I status has created countless hurdles that simply don’t exist for studies on other controlled substances.
LSD and heroin, are also Schedule I substances, yet methanphetamine is classified as Schedule II. Meaning, according to the Federal Government, meth has “Medical Value” while cannabis has none.
The California Resolution, which passed the state Senate with a staggering 34/2 margin, also calls for changes to federal law to allow “legal commerce of marijuana or cannabis so that businesses dealing with marijuana or cannabis can use traditional banks or financial instituitons for their banking needs, which would result in providing a legal vehicle for those businesses to pay their taxes.”
As stated in U.S. Code § 280E: